Cell and gene therapy

Cell and gene therapy
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statistics report about the cell and gene therapy industry

This dossier presents key facts and figures about the cell and gene therapy industry. Cell and gene therapies are especially well-known in the treatment of cancer. The document provides information on the total market and submarkets, regional distribution, the cord blood bank system, forecasts, etc.

Table of contents

    • Global market size for regenerative medicine 2021-2030

    • Global cell and gene therapy manufacturing market forecast 2020-2030

    • Global cell culture market size 2022-2030

    • ATMP classification share worldwide 2016

    • Regenerative medicine companies by world region 2023

    • Market cap of gene and cell therapy companies 2023

    • ATMP trials classification share by disease and development phase globally 2016

    • ATMP clinical trials share globally by type of sponsor

    • ATMP clinical trials non-commercial sponsors distribution globally 2016

    • Number of biotech therapies in development as of 2017, by developer

    • Percentage of biotech therapies in development as of 2017, by developer

    • Global stem cell market size by world region 2011-2016

    • Stem cell technologies and applications market share by world region 2016

    • Global stem cell market size forecast 2022-2030

    • Number of HSC transplants in the US from 2010-2015, by source

    • Total stem cell research funding by the National Institutes for Health 2013-2024

    • Aggregate annual demand for cord blood units from 2010-2016

    • Annual social value of U.S. CBB system by scenario 2010-2016

    • Percentage of CBUs from the U.S. shipped domestically and internationally 2010-2016

    • Percentage of shipped U.S. cord blood units by TNC count 2002-2016

    • Percentage of stored U.S. CBUs by TNC count 2002-2016

    • Number of CAR cell therapy trials worldwide 2007-2016

    • Number of CAR cell therapy trials U.S. vs China 2009-2016

    • Venture capital funding for companies in CAR-T programs 2011-2016

    • IPO value of select CAR-T companies 2013-2015

    • Length of hospital stay for an HSC transplant in the U.S. in 2014, by procedure

    • Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure

    • Capital raised by regenerative medicine companies worldwide 2016-2022

    • Select market-stage ATMPs price in the U.S. as of 2016

    • View of increasing government funding for stem cell research - U.S. adults 2017

Order report
More than 7,500
companies trust
Statista

Recommended reports

Recent reports

You may also be interested in...

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Contact
Vayola Jocelyn
Client Support Specialist
support@statista.com +1 212 419-8219

Mon - Fri, 9am - 6pm, EST

Contact (Europe)
Lodovica Biagi
Director of Operations EMEA
eu.support@statista.com +44 (0)20 8189 7000

Mon - Fri, 9:30am - 5pm, GMT

Download your Report

We value your privacy and will never rent or sell your email address.

Privacy

Menu